Open Access1ISG-019 A cost-effectiveness analysis of biological therapies for moderate to severe psoriasis
Author(s) -
A Andrés Rosado,
AB Fernández Román,
N Herrero Muñoz,
M.G. Gil
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.19
Subject(s) - medicine , ustekinumab , infliximab , adalimumab , secukinumab , psoriasis , etanercept , psoriasis area and severity index , ixekizumab , cost effectiveness , clinical trial , physical therapy , psoriatic arthritis , dermatology , disease , rheumatoid arthritis , risk analysis (engineering)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom